Zomedica Corp [ZOM] stock is trading at $0.14, up 4.72%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ZOM shares have gain 9.30% over the last week, with a monthly amount glided 14.20%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 20, March 2024, Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET. In a post published today on Yahoo Finance, Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Monday, April 1st, 2024, at 4:30 p.m. ET to discuss the Company’s operational and financial highlights for its fourth quarter and full year ended December 31, 2023. A question-and-answer session will follow management’s prepared remarks.
From an analyst’s perspective:
Zomedica Corp [AMEX: ZOM] stock has seen the most recent analyst activity on January 06, 2023, when Dawson James initiated its Buy rating and assigned the stock a price target of $6.
Zomedica Corp [ZOM] stock has fluctuated between $0.12 and $0.25 over the past year. Zomedica Corp [AMEX: ZOM] shares were valued at $0.14 at the most recent close of the market.
Analyzing the ZOM fundamentals
Zomedica Corp [AMEX:ZOM] reported sales of 24.01M for the trailing twelve months, which represents a growth of 32.89%. Gross Profit Margin for this corporation currently stands at 0.69% with Operating Profit Margin at -1.06%, Pretax Profit Margin comes in at -0.74%, and Net Profit Margin reading is -0.62%. To continue investigating profitability, this company’s Return on Assets is posted at -0.05, Equity is -0.06 and Total Capital is -0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.1366 points at the first support level, and at 0.1333 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.1416, and for the 2nd resistance point, it is at 0.1433.
Zomedica Corp [ZOM] reported earnings per share of $0 for its fiscal quarter that ended on 9/29/2023.
Ratios To Look Out For
For context, Zomedica Corp’s Current Ratio is 17.12. Also, the Quick Ratio is 16.57, while the Cash Ratio stands at 3.23. Considering the valuation of this stock, the price to sales ratio is 5.71, the price to book ratio is 0.53.
Transactions by insiders
Recent insider trading involved POWERS JOHNNY D, Director, that happened on Dec 15 ’23 when 100000.0 shares were purchased. Director, POWERS JOHNNY D completed a deal on Nov 17 ’23 to buy 100000.0 shares. Meanwhile, CEO HEATON LARRY C II bought 100000.0 shares on Nov 17 ’23.
